Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel Galinier is active.

Publication


Featured researches published by Michel Galinier.


PLOS ONE | 2011

Blood signature of pre-heart failure: a microarrays study.

Fatima Smih; Franck Desmoulin; Matthieu Berry; Annie Turkieh; Romain Harmancey; Jason Iacovoni; Charlotte Trouillet; Clément Delmas; Atul Pathak; Olivier Lairez; François Koukoui; Pierre Massabuau; Jean Ferrières; Michel Galinier; Philippe Rouet

Background The preclinical stage of systolic heart failure (HF), known as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by echocardiography, frequent in the general population and leads to a high risk of developing severe HF. Large scale screening for ALVD is a difficult task and represents a major unmet clinical challenge that requires the determination of ALVD biomarkers. Methodology/Principal Findings 294 individuals were screened by echocardiography. We identified 9 ALVD cases out of 128 subjects with cardiovascular risk factors. White blood cell gene expression profiling was performed using pangenomic microarrays. Data were analyzed using principal component analysis (PCA) and Significant Analysis of Microarrays (SAM). To build an ALVD classifier model, we used the nearest centroid classification method (NCCM) with the ClaNC software package. Classification performance was determined using the leave-one-out cross-validation method. Blood transcriptome analysis provided a specific molecular signature for ALVD which defined a model based on 7 genes capable of discriminating ALVD cases. Analysis of an ALVD patients validation group demonstrated that these genes are accurate diagnostic predictors for ALVD with 87% accuracy and 100% precision. Furthermore, Receiver Operating Characteristic curves of expression levels confirmed that 6 out of 7 genes discriminate for left ventricular dysfunction classification. Conclusions/Significance These targets could serve to enhance the ability to efficiently detect ALVD by general care practitioners to facilitate preemptive initiation of medical treatment preventing the development of HF.


Clinical Medicine Insights: Cardiology | 2009

Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session

Jérôme Roncalli; L. Perez; Atul Pathak; Laure Spinazze; Sandrine Mazon; Olivier Lairez; Daniel Curnier; Joelle Fourcade; Meyer Elbaz; Didier Carrié; Jacques Puel; Jean-Marie Fauvel; Michel Galinier

Background Interest in the role of patient education sessions for optimizing the management of heart failure (HF) is increasing. We determined whether improvements in young and elderly patients knowledge of HF and self-care behavior could be analyzed by administering a knowledge test before and after an educational session. Methods Stable heart failure patients (n = 115) were enrolled in a prospective cohort study from our Heart Failure educational centre in a university hospital. Patient knowledge of six major HF-related topics was assessed via a questionnaire distributed once before an educational session and twice afterward. Each answer was assigned a numerical value and the final score for each topic could range from 0 to 20. Scores ≥ 15/20 were considered representative of a good level of knowledge. Results The level of knowledge was low (9.7/20) before the educational session but was significantly higher (16.3/20) during the 1st quarter after the session, and this benefit was maintained for up to 12 months (16.6/20). Knowledge levels increased in both younger and elderly patients, and the number of patients who had a good level of knowledge also increased after the educational session. Conclusion This study confirms that an HF knowledge test is feasible and that educational sessions improve the knowledge and self-management of both younger and elderly patients.


Journal of Molecular and Cellular Cardiology | 2007

NMR and cDNA array analysis prior to heart failure reveals an increase of unsaturated lipids, a glutamine/glutamate ratio decrease and a specific transcriptome adaptation in obese rat heart

Jérôme Roncalli; F. Smih; Franck Desmoulin; N. Dumonteil; R. Harmancey; S. Hennig; L. Perez; Atul Pathak; Michel Galinier; P. Massabuau; Myriam Malet-Martino; J.M. Senard; Philippe Rouet


European Research in Telemedicine / La Recherche Européenne en Télémédecine | 2014

Optimization of ambulatory monitoring of patients with heart failure using telecardiology (OSICAT)

H. Bendelac; Atul Pathak; L. Molinier; J.-B. Ruidavets; A. Mayère; M. Berry; C. Delmas; Jérôme Roncalli; Michel Galinier


MT Cardio | 2006

Chemoreflexes from physiology to practice

Fabien Despas; Olivier Xhaet; Jean-Michel Senard; Patrick Verwaerde; Géraldine Jourdan; Daniel Curnier; Michel Galinier; Atul Pathak


/data/revues/00029149/unassign/S0002914914000587/ | 2014

Prevalence of Memory Disorders in Ambulatory Patients Aged ?70 Years With Chronic Heart Failure (from the EFICARE Study)

Olivier Hanon; Jean-Sébastien Vidal; Pascal de Groote; Michel Galinier; Richard Isnard; Damien Logeart; Michel Komajda


Archive | 2013

Diagnostic de l'insuffisance cardiaque

Philippe Rouet; Fatima Smih-rouet; Franck Desmoulin; Michel Galinier


Archive | 2010

Heart Failure: The STARS-BNP Multicenter Study Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in

Alain Cohen-Solal; Erwan Donal; Jean F. Aupetit; Marie Claude Aumont; Michel Galinier; Jean C. Patrick Jourdain; G. Jondeau; François Funck; Pascal Gueffet


Archive | 2010

Variations in duration and composition of the excitable gap around the tricuspid annulus during typical atrial flutter Variations dans la durée et la composition de la fenêtre d'excitabilité du flutter atrial typique autour de l'anneau tricuspidien

Philippe Maury; Joelle Fourcade; Alexandre Duparc; Anne Rollin; Nicolas Detis; Aurélien Hébrard; Marc Delay; Meyer Elbaz; Didier Carrié; Michel Galinier


/data/revues/18786480/00020001/30_2/ | 2010

Iconographies supplémentaires de l'article : 090 - Direct involvement of Bortezomib in the occurrence of heart failure

Benjamin Honton; Nicolas Dumonteil; Caroline Rouvellat; Murielle Roussel; Fabien Despas; Didier Carrié; Michel Galinier; Atul Pathak

Collaboration


Dive into the Michel Galinier's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Meyer Elbaz

University of Toulouse

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atul Pathak

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Curnier

Paul Sabatier University

View shared research outputs
Researchain Logo
Decentralizing Knowledge